New combo approach aims to stop pneumonia in ventilated patients

NCT ID NCT07555236

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using two automated devices together—one that drains fluids from above the breathing tube and another that monitors the tube's cuff pressure—can reduce the amount of fluid entering the lungs of critically ill patients on ventilators. The goal is to prevent ventilator-associated pneumonia, a serious infection. 800 adults in intensive care will be randomly assigned to one of four groups to compare the combined approach against each device alone or standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a standard care approach that reduces ventilator-associated pneumonia in intensive care units.

What could go wrong

This is an early-stage trial (not yet recruiting) and results may not show a clear benefit over standard care. The outcome is based on enzyme levels, not directly on pneumonia rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA, VENTILATOR-ASSOCIATED HEALTHCARE-ASSOCIATED PNEUMONIA RESPIRATION, ARTIFICIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••